Original Literature | Model OverView |
---|---|
Publication
Title
Pathogen recognition with Toll-like receptors.
Affiliation
Exploratory Research for Advanced Technology (ERATO), Japan Science andTechnology Agency, 3-1 Yamada-oka, Suita, Osaka 565-0871, Japan.
Abstract
The innate immune system is an evolutionarily conserved system of defenseagainst microbial infections. The family of Toll-like receptors is a major classof receptors that sense molecular patterns associated with a broad range ofpathogens including bacteria, viruses, fungi and protozoa. Following pathogenrecognition, Toll-like receptors initiate intracellular signal transduction thatresults in the expression of genes involved in inflammation, antiviral responsesand maturation of dendritic cells. Individual Toll-like receptors activatecommon and unique transcription factors through different signaling pathways todrive specific biological responses against microorganisms.
PMID
15950447
|
Entity
Process
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19
10
infinite
0
TRANSPATH | MO000000058 |
--
TRAF6
--
MO000000212
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m183
10
infinite
0
InterPro | IPR001841 |
TRANSPATH | MO000000212 |
--
MyD88
--
MO000016573
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m1572
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000016573 |
--
IFN Type I
--
MO000016658
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m1634
10
infinite
0
TRANSPATH | MO000016658 |
--
IKK-alpha:IKK-beta:IKK-gamma
--
MO000016661
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m1637
10
infinite
0
TRANSPATH | MO000016661 |
--
TLR2
--
MO000019397
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m3964
10
infinite
0
InterPro | IPR000157 |
TRANSPATH | MO000019397 |
--
protein remnants
--
MO000019479
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m360980
10
infinite
0
TRANSPATH | MO000019479 |
--
ERK{p}
--
MO000038306
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m16522
10
infinite
0
TRANSPATH | MO000038306 |
--
dsRNA:TLR3
--
MO000041446
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19314
10
infinite
0
TRANSPATH | MO000041446 |
--
IRF-3{p}
--
MO000041456
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19324
10
infinite
0
TRANSPATH | MO000041456 |
--
IRF-7{p}
--
MO000041457
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19325
10
infinite
0
TRANSPATH | MO000041457 |
--
TLR8(h)
--
MO000042006
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m155646
10
infinite
0
Affymetrix | 220832_at |
Ensembl | ENSG00000101916 |
HGNC | TLR8 |
OMIM | 300366 |
Proteome | HumanPSD/TLR8 |
RefSeq | NM_016610 |
TRANSPATH | MO000042006 |
Unigene | Hs.272410 |
UniProt | Q9NR97 |
--
PGN
--
MO000042032
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m155701
10
infinite
0
TRANSPATH | MO000042032 |
--
TLR7
--
MO000042126
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19940
10
infinite
0
TRANSPATH | MO000042126 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
IRF-5{activated}
--
e100
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m103
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007700 |
--
IRF-5: proinflammatory cytokines
--
e102
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m105
0
infinite
0
--
proinflammatory cytokines
--
e103
cso30:c:Dna
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m106
0
infinite
0
--
proinflammatory cytokines
--
e104
cso30:c:Rna
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m107
0
infinite
0
--
IRF-8{activated}
--
e105
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m108
10
infinite
0
InterPro | IPR008984 |
TRANSPATH | MO000007185 |
--
IL-12p70
--
e106
cso30:c:Rna
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m109
0
infinite
0
--
IFN Type I
--
e107
cso30:c:mRNA
cso30:i:CC_Cytosol
--
csml-variable:Double
m111
0
infinite
0
--
RIG-1
--
e108
cso30:c:Protein
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m112
0
infinite
0
--
csml-variable:Double
m113
0
infinite
0
--
TLR2: TLR1
--
e11
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m11
0
infinite
0
--
PGN: Nod1
--
e110
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m114
0
infinite
0
--
PGN: NOD2
--
e111
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m115
0
infinite
0
--
protein remnants: NOD1
--
e112
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m116
0
infinite
0
--
protein remnants: NOD2
--
e113
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m117
0
infinite
0
--
tri-acyi lipopeptide
--
e12
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m12
0
infinite
0
--
Di-acyl lipopeptide
--
e13
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m13
0
infinite
0
--
Di-acyl lipopeptide: TLR2: TLR6
--
e14
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m14
0
infinite
0
--
tri-acyi lipopeptide: TLR2: TLR1
--
e15
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
csml-variable:Double
m15
0
infinite
0
--
PAMPs
--
e16
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m16
0
infinite
0
--
PAMP: TLR
--
e17
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m17
0
infinite
0
--
flagellin: TLR5
--
e18
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m18
0
infinite
0
--
uropathogenic bacterial ligand: TLR11
--
e19
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m20
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
uropathogenic bacterial ligand
--
e20
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m21
0
infinite
0
--
csml-variable:Double
m22
0
infinite
0
--
CpG DNA: TLR9
--
e22
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m23
0
infinite
0
--
homozoin: TLR9
--
e23
cso30:c:Complex
cso30:i:CC_EndosomeMembrane
--
--
csml-variable:Double
m24
0
infinite
0
--
csml-variable:Double
m25
0
infinite
0
--
viral ssRNA
--
e25
cso30:c:Rna
cso30:i:CC_Extracellular
--
csml-variable:Double
m26
0
infinite
0
--
viral ssRNA: TLR8
--
e26
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
--
csml-variable:Double
m27
0
infinite
0
--
viral ssRNA: TLR7
--
e27
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m28
0
infinite
0
--
PGN: TLR2
--
e28
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m29
0
infinite
0
--
lipopeptides
--
e29
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m30
0
infinite
0
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
lipopeptides: TLR2
--
e30
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m31
0
infinite
0
--
Lp: TLR2
--
e31
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m32
0
infinite
0
--
dectin-1
--
e32
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m33
0
infinite
0
--
zymosan
--
e33
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m34
0
infinite
0
--
zymosan: TLR2: dectin-1
--
e34
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
csml-variable:Double
m35
0
infinite
0
--
TLR ligands
--
e35
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m36
0
infinite
0
--
TLR2 ligands: CD36
--
e36
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m37
0
infinite
0
--
CD36
--
e37
cso30:c:Protein
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m38
0
infinite
0
--
target genes
--
e38
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m39
0
infinite
0
--
resiquimod
--
e39
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
csml-variable:Double
m40
0
infinite
0
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
resiquimod: TLR8{h}
--
e40
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
--
csml-variable:Double
m41
0
infinite
0
--
resiquimod: TLR7
--
e41
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
--
csml-variable:Double
m42
0
infinite
0
--
imiquimod
--
e42
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
csml-variable:Double
m43
0
infinite
0
--
imiquimod: TLR8{h}
--
e43
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
--
csml-variable:Double
m44
0
infinite
0
--
imiquimod: TLR7
--
e44
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
--
csml-variable:Double
m45
0
infinite
0
--
loxoribine
--
e45
cso30:c:SmallMolecule
cso30:i:CC_Extracellular
--
csml-variable:Double
m46
0
infinite
0
--
loxoribine: TLR8{h}
--
e46
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
--
csml-variable:Double
m47
0
infinite
0
--
loxoribine: TLR8{h}
--
e47
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
--
csml-variable:Double
m48
0
infinite
0
--
West Nile Viru sligand: TLR3
--
e48
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
--
csml-variable:Double
m49
0
infinite
0
--
West Nile Viru sligand
--
e49
cso30:c:Protein
cso30:i:CC_Extracellular
--
--
csml-variable:Double
m63
0
infinite
0
--
LPS: TLR4
--
e5
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
csml-variable:Double
m5
0
infinite
0
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
TLR2: TLR6
--
e6
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
PAMPs: TLR: MyD88
--
e63
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m64
0
infinite
0
--
PAMPs: TLR: MyD88 : IRAK-1: IRAK-4
--
e64
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m65
0
infinite
0
--
PAMPs: TLR: MyD88 : IRAK-1: IRAK-4{p}
--
e65
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m66
0
infinite
0
--
LPS: TLR4: MAL
--
e66
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m67
0
infinite
0
--
PAMPs: TLR: MyD88 : IRAK-1{p}: IRAK-4{p}
--
e67
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m68
0
infinite
0
--
IRAK-1{p}: IRAK-4{p}
--
e68
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m69
0
infinite
0
--
IRAK-1{p}: IRAK-4{p}: TRAF6
--
e69
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m70
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
IRAK-1{p}: IRAK-4{p}: TRAF6: TAK1
--
e70
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m71
0
infinite
0
--
MAPKs{activated}
--
e71
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m73
10
infinite
0
TRANSPATH | MO000000077 |
--
IKK-alpha:IKK-beta:IKK-gamma{activated}
--
e72
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m74
10
infinite
0
TRANSPATH | MO000016661 |
--
NF-kappaB{activated}
--
e73
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m75
10
infinite
0
TRANSPATH | MO000000058 |
--
NF-kappaB{nucleus}
--
e75
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m77
10
infinite
0
TRANSPATH | MO000000058 |
--
LPS: TLR4: MAL: MyD88
--
e76
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m78
0
infinite
0
--
csml-variable:Double
m79
0
infinite
0
--
Lp: TLR2: MAL: MyD88
--
e78
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m80
0
infinite
0
--
LPS: TLR4: TRAM
--
e79
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m81
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
LPS: TLR4: TRAM: TRIF
--
e80
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m82
0
infinite
0
--
dsRNA: TLR3: TRIF
--
e81
cso30:c:Complex
cso30:i:CC_EndosomeMembrane
--
csml-variable:Double
m83
0
infinite
0
--
TBK1{activated}
--
e82
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m84
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000019331 |
--
IKK-i{activated}
--
e83
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m85
10
infinite
0
InterPro | IPR000719 |
TRANSPATH | MO000016608 |
--
IRF-3{p}{nucleus}
--
e84
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m86
10
infinite
0
TRANSPATH | MO000041456 |
--
IFN inducible gene
--
e85
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
--
csml-variable:Double
m87
0
infinite
0
--
LPS: TLR4: TRAM: TRIF
--
e86
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
csml-variable:Double
m89
0
infinite
0
--
dsRNA: TLR3: TRIF: RIP1
--
e87
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m90
0
infinite
0
--
dsRNA: TLR3: TRIF: RIP1: TRAF6
--
e88
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m91
0
infinite
0
--
viral ssRNA: TLR7: MyD88
--
e89
cso30:c:Complex
cso30:i:CC_EndosomeMembrane
--
--
csml-variable:Double
m92
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
CpG DNA: TLR9: MyD88
--
e90
cso30:c:Complex
cso30:i:CC_EndosomeMembrane
--
csml-variable:Double
m93
0
infinite
0
--
viral ssRNA: TLR7: MyD88: IRAK-1{p}: IRAK-4{p}
--
e91
cso30:c:Complex
cso30:i:CC_Cytosol
--
--
csml-variable:Double
m94
0
infinite
0
--
viral ssRNA: TLR7: MyD88: IRAK-1{p}: IRAK-4{p}: TRAF6
--
e92
cso30:c:Complex
cso30:i:CC_EndosomeMembrane
--
csml-variable:Double
m95
0
infinite
0
--
CpG DNA: TLR9: MyD88: IRAK-1{p}: IRAK-4{p}
--
e93
cso30:c:Complex
cso30:i:CC_EndosomeLumen
--
csml-variable:Double
m96
0
infinite
0
--
CpG DNA: TLR9: MyD88: IRAK-1{p}: IRAK-4{p}: TRAF6
--
e94
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m97
0
infinite
0
--
viral ssRNA: TLR7: MyD88: IRAK-1{p}: IRAK-4{p}: TRAF6: IRF-7
--
e95
cso30:c:Complex
cso30:i:CC_EndosomeMembrane
--
csml-variable:Double
m98
0
infinite
0
--
CpG DNA: TLR9: MyD88: IRAK-1{p}: IRAK-4{p}: IRF-7
--
e96
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m99
0
infinite
0
--
IRF-7{p}{nucleus}
--
e97
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m100
10
infinite
0
TRANSPATH | MO000041457 |
--
PAMPs: TLR: MyD88 : IRAK-1{p}: IRAK-4{p}: TRAF6
--
e98
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m101
0
infinite
0
--
PAMPs: TLR: MyD88 : IRAK-1{p}: IRAK-4{p}: TRAF6: IRF-5
--
e99
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m102
0
infinite
0
--
p1
p1
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
stoichiometry:c6 : 1
m155666*m3961*0.1
nodelay
--
0
PMID: 15950447 TLR4 recognizes bacterial LPS.
p10
p10
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c28 : 1
stoichiometry:c30 : 1
stoichiometry:c33 : 1
m26*m19823*0.1
nodelay
--
0
PMID: 15950447 TLR3, TLR7, TLR8 and TLR9 reside in endosomal compartments and recognize nucleic acids; TLR3 recognizes viral dsRNA, whereas TLR7 and TLR8 recognize viral ssRNA.
p11
p11
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c29 : 1
stoichiometry:c31 : 1
stoichiometry:c32 : 1
m26*m19940*0.1
nodelay
--
0
PMID: 15950447 TLR3, TLR7, TLR8 and TLR9 reside in endosomal compartments and recognize nucleic acids; TLR3 recognizes viral dsRNA, whereas TLR7 and TLR8 recognize viral ssRNA.
p12
p12
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c34 : 1
stoichiometry:c35 : 1
stoichiometry:c36 : 1
m155701*m3964*0.1
nodelay
--
0
PMID: 15950447, 12524386, 10549626 TLR2 recognizes peptidoglycan, in addition to the lipoproteins and lipopeptides of Gram-positive bacteria and mycoplasma lipopeptide.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c38 : 1
stoichiometry:c39 : 1
m3964*m30*0.1
nodelay
--
0
PMID: 15950447, 12524386, 10549626 TLR2 recognizes peptidoglycan, in addition to the lipoproteins and lipopeptides of Gram-positive bacteria and mycoplasma lipopeptide.
p14
p14
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c40 : 1
stoichiometry:c41 : 1
stoichiometry:c42 : 1
m3964*m2549*0.1
nodelay
--
0
PMID: 15950447, 12524386, 10549626 TLR2 recognizes peptidoglycan, in addition to the lipoproteins and lipopeptides of Gram-positive bacteria and mycoplasma lipopeptide.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c43 : 1
stoichiometry:c44 : 1
stoichiometry:c45 : 1
stoichiometry:c46 : 1
m33*m34*m3964*0.1
nodelay
--
0
PMID: 15950447, 12719479 Innate immune responses against zymosan, a cell-wall preparation of yeast, are mediated by the collaborative recognition of TLR2 and dectin-1, a lectin family of receptors for beta-glucans.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c47 : 1
stoichiometry:c48 : 1
stoichiometry:c49 : 1
m38*m36*0.1
nodelay
--
0
PMIID: 15950447, 15690042 CD36, a class II scavenger receptor expressed on the surface of innate immune cells, is involved in sensing some, but not all, TLR2 ligands.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c51 : 1
stoichiometry:c50 : 1
m35*0.1
nodelay
--
0
PMID: 15950447 Signaling through dectin-1 enhanced the TLR2-mediated transcription of target genes.
p18
p18
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c53 : 1
stoichiometry:c52 : 1
stoichiometry:c54 : 1
m40*m155646*0.1
nodelay
--
0
PMID: 15950447, 12032557 TLR8 is a close relative of TLR7, and a transfection study has demonstrated that human, but not mouse, TLR8 confers responsiveness to resiquimod.
p19
p19
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c55 : 1
stoichiometry:c57 : 1
stoichiometry:c56 : 1
m40*m19940*0.1
nodelay
--
0
PMID: 15950447 Synthetic imidazoquinoline-like molecules imiquimod (R-837) and resiquimod (R-848), and guanosine analogs such as loxoribine, have potent antiviral activities and are currently used for treating viral infections. PMID: 15950447 Taken together, these findings indicate that mouse TLR7, human TLR7 and human TLR8 mediate the recognition of these molecules.
p2
p2
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m119368*m3965*0.1
nodelay
--
0
PMID: 15950447 TLR3 recognizes viral dsRNA.
p20
p20
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c58 : 1
stoichiometry:c59 : 1
stoichiometry:c60 : 1
m43*m155646*0.1
nodelay
--
0
PMID: 15950447 Synthetic imidazoquinoline-like molecules imiquimod (R-837) and resiquimod (R-848), and guanosine analogs such as loxoribine, have potent antiviral activities and are currently used for treating viral infections. PMID: 15950447 Taken together, these findings indicate that mouse TLR7, human TLR7 and human TLR8 mediate the recognition of these molecules.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c61 : 1
stoichiometry:c62 : 1
stoichiometry:c63 : 1
m43*m19940*0.1
nodelay
--
0
PMID: 15950447 Synthetic imidazoquinoline-like molecules imiquimod (R-837) and resiquimod (R-848), and guanosine analogs such as loxoribine, have potent antiviral activities and are currently used for treating viral infections. PMID: 15950447 Taken together, these findings indicate that mouse TLR7, human TLR7 and human TLR8 mediate the recognition of these molecules.
p22
p22
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c64 : 1
stoichiometry:c65 : 1
stoichiometry:c66 : 1
m46*m155646*0.1
nodelay
--
0
PMID: 15950447 Synthetic imidazoquinoline-like molecules imiquimod (R-837) and resiquimod (R-848), and guanosine analogs such as loxoribine, have potent antiviral activities and are currently used for treating viral infections. PMID: 15950447 Taken together, these findings indicate that mouse TLR7, human TLR7 and human TLR8 mediate the recognition of these molecules.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c68 : 1
m46*0.1
nodelay
--
0
PMID: 15950447 Synthetic imidazoquinoline-like molecules imiquimod (R-837) and resiquimod (R-848), and guanosine analogs such as loxoribine, have potent antiviral activities and are currently used for treating viral infections. PMID: 15950447 Taken together, these findings indicate that mouse TLR7, human TLR7 and human TLR8 mediate the recognition of these molecules.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c69 : 1
stoichiometry:c71 : 1
stoichiometry:c70 : 1
m3965*m63*0.1
nodelay
--
0
PMID: 15950447, 15558055 TLR3 also mediates the recognition of West Nile virus (WNV).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c72 : 1
stoichiometry:c73 : 1
stoichiometry:c74 : 1
m17*m1572*0.1
nodelay
--
0
PMID: 15950447 MyD88 is utilized by all TLRs, with the exception of TLR3.
p26
p26
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c75 : 1
stoichiometry:c76 : 1
stoichiometry:c78 : 1
stoichiometry:c77 : 1
m184*m64*m17258*0.1
nodelay
--
0
PMID: 15950447 The association of TLRs and MyD88 recruits members of the IL-1 receptor-associated kinase (IRAK) family; two members, IRAK4 and IRAK1, are sequentially phosphorylated, causing them to dissociate from the receptor complex, and then associate with TRAF6.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c79 : 1
stoichiometry:c80 : 1
m65*0.1
nodelay
--
0
PMID: 15950447 The association of TLRs and MyD88 recruits members of the IL-1 receptor-associated kinase (IRAK) family; two members, IRAK4 and IRAK1, are sequentially phosphorylated, causing them to dissociate from the receptor complex, and then associate with TRAF6.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c81 : 1
stoichiometry:c82 : 1
m66*0.1
nodelay
--
0
PMID: 15950447 The association of TLRs and MyD88 recruits members of the IL-1 receptor-associated kinase (IRAK) family; two members, IRAK4 and IRAK1, are sequentially phosphorylated, causing them to dissociate from the receptor complex, and then associate with TRAF6.
p29
p29
cso30:i:ME_Dissociation
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c83 : 1
stoichiometry:c84 : 1
stoichiometry:c85 : 1
m68*0.1
nodelay
--
0
PMID: 15950447 The association of TLRs and MyD88 recruits members of the IL-1 receptor-associated kinase (IRAK) family; two members, IRAK4 and IRAK1, are sequentially phosphorylated, causing them to dissociate from the receptor complex, and then associate with TRAF6.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c9 : 1
m13*m6*0.1
nodelay
--
0
PMID: 15950447 Structures and ligands for Toll-like receptors. TLR2, in collaboration with TLR1 or TLR6, discriminates between the molecular structures of triacyl and diacyl lipopeptides, respectively.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c86 : 1
stoichiometry:c87 : 1
stoichiometry:c88 : 1
m69*m183*0.1
nodelay
--
0
PMID: 15950447 The association of TLRs and MyD88 recruits members of the IL-1 receptor-associated kinase (IRAK) family; two members, IRAK4 and IRAK1, are sequentially phosphorylated, causing them to dissociate from the receptor complex, and then associate with TRAF6.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c89 : 1
stoichiometry:c90 : 1
stoichiometry:c91 : 1
m70*m1573*0.1
nodelay
--
0
PMID: 15950447 TRAF6 forms a complex with ubiquitin-conjugating enzymes to activate the kinase TAK1, which in turn activates transcription factors nuclear factor (NF)-kappaB and activator protein-1 through the canonical IkappaB kinase (IKK) complex and the mitogen-activated protein kinase pathway, respectively.
p32
p32
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c96 : 1
stoichiometry:c97 : 1
m71*m72*0.1
nodelay
--
0
PMID: 15950447 TRAF6 forms a complex with ubiquitin-conjugating enzymes to activate the kinase TAK1, which in turn activates transcription factors nuclear factor (NF)-kappaB and activator protein-1 through the canonical IkappaB kinase (IKK) complex and the mitogen-activated protein kinase pathway, respectively.
p33
p33
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c92 : 1
stoichiometry:c94 : 1
stoichiometry:c95 : 1
m71*m1637*0.1
nodelay
--
0
PMID: 15950447 TRAF6 forms a complex with ubiquitin-conjugating enzymes to activate the kinase TAK1, which in turn activates transcription factors nuclear factor (NF)-kappaB and activator protein-1 through the canonical IkappaB kinase (IKK) complex and the mitogen-activated protein kinase pathway, respectively.
p34
p34
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c98 : 1
stoichiometry:c100 : 1
stoichiometry:c99 : 1
m19*m74*0.1
nodelay
--
0
PMID: 15950447 TRAF6 forms a complex with ubiquitin-conjugating enzymes to activate the kinase TAK1, which in turn activates transcription factors nuclear factor (NF)-kappaB and activator protein-1 through the canonical IkappaB kinase (IKK) complex and the mitogen-activated protein kinase pathway, respectively.
p35
p35
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c101 : 1
stoichiometry:c105 : 1
stoichiometry:c102 : 1
m219*m73*0.1
nodelay
--
0
PMID: 15950447 TRAF6 forms a complex with ubiquitin-conjugating enzymes to activate the kinase TAK1, which in turn activates transcription factors nuclear factor (NF)-kappaB and activator protein-1 through the canonical IkappaB kinase (IKK) complex and the mitogen-activated protein kinase pathway, respectively.
p36
p36
cso30:i:ME_Translocation
cso30:i:CC_NuclearInnerMembrane
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c103 : 1
stoichiometry:c104 : 1
m75*0.1
nodelay
--
0
PMID: 15950447, 15229469, 10435584 NF-kappaB activation by this ¡ÆMyD88-dependent pathway¡Ç results in the expression of inflammatory cytokine genes, including tumor necrosis factor-alpha, IL-6 and IL-1beta.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c109 : 1
stoichiometry:c106 : 1
m77*0.1
nodelay
--
0
PMID: 15950447, 15229469, 10435584 NF-kappaB activation by this ¡ÆMyD88-dependent pathway¡Ç results in the expression of inflammatory cytokine genes, including tumor necrosis factor-alpha, IL-6 and IL-1beta.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c110 : 1
stoichiometry:c107 : 1
m77*0.1
nodelay
--
0
PMID: 15950447, 15229469, 10435584 NF-kappaB activation by this ¡ÆMyD88-dependent pathway¡Ç results in the expression of inflammatory cytokine genes, including tumor necrosis factor-alpha, IL-6 and IL-1beta.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c111 : 1
stoichiometry:c108 : 1
m77*0.1
nodelay
--
0
PMID: 15950447, 15229469, 10435584 NF-kappaB activation by this ¡ÆMyD88-dependent pathway¡Ç results in the expression of inflammatory cytokine genes, including tumor necrosis factor-alpha, IL-6 and IL-1beta.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c10 : 1
stoichiometry:c11 : 1
stoichiometry:c12 : 1
m12*m11*0.1
nodelay
--
0
PMID: 15950447 Structures and ligands for Toll-like receptors. TLR2, in collaboration with TLR1 or TLR6, discriminates between the molecular structures of triacyl and diacyl lipopeptides, respectively.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c112 : 1
stoichiometry:c113 : 1
stoichiometry:c114 : 1
m5*m43675*0.1
nodelay
--
0
PMID: 15950447, 12447441, 12447442 Among these adapters, TIRAP?MAL is required for the activation of the MyD88-dependent pathway downstream of TLR2 and TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c115 : 1
stoichiometry:c117 : 1
stoichiometry:c116 : 1
m67*m1572*0.1
nodelay
--
0
PMID: 15950447, 12447441, 12447442 Among these adapters, TIRAP?MAL is required for the activation of the MyD88-dependent pathway downstream of TLR2 and TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c119 : 1
stoichiometry:c118 : 1
stoichiometry:c120 : 1
m43675*m32*0.1
nodelay
--
0
PMID: 15950447, 12447441, 12447442 Among these adapters, TIRAP?MAL is required for the activation of the MyD88-dependent pathway downstream of TLR2 and TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c121 : 1
stoichiometry:c122 : 1
stoichiometry:c123 : 1
m1572*m79*0.1
nodelay
--
0
PMID: 15950447, 12447441, 12447442 Among these adapters, TIRAP?MAL is required for the activation of the MyD88-dependent pathway downstream of TLR2 and TLR4.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c124 : 1
stoichiometry:c125 : 1
stoichiometry:c126 : 1
m5*m19005*0.1
nodelay
--
0
PMID: 15950447, 14556004 Additionally, TLR4 also requires another adaptor, TRAM, for IRF3 activation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c130 : 1
stoichiometry:c132 : 1
stoichiometry:c131 : 1
m81*m18998*0.1
nodelay
--
0
PMID: 15950447, 12855817, 12872135 It has been demonstrated that TRIF is responsible for TLR3- and TLR4-mediated IRF3 activation.
p46
p46
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c127 : 1
stoichiometry:c128 : 1
stoichiometry:c129 : 1
m18998*m19314*0.1
nodelay
--
0
PMID: 15950447, 12855817, 12872135 It has been demonstrated that TRIF is responsible for TLR3- and TLR4-mediated IRF3 activation.
p47
p47
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c133 : 1
stoichiometry:c141 : 1
stoichiometry:c134 : 1
m3902*m82*0.1
nodelay
--
0
PMID: 15950447, 12692549, 12702806 IRF3 activation occurs through the actions of the IKK-related kinases TRAF-family-member-associated NF-¦ÊB activator (TANK)-binding kinase 1 (TBK1) and IKKi (also called IKKvar epsilon), which catalyze IRF3 phosphorylation and stimulate its nuclear translocation and DNA binding.
p48
p48
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c135 : 1
stoichiometry:c143 : 1
stoichiometry:c136 : 1
m3902*m83*0.1
nodelay
--
0
PMID: 15950447, 12692549, 12702806 IRF3 activation occurs through the actions of the IKK-related kinases TRAF-family-member-associated NF-¦ÊB activator (TANK)-binding kinase 1 (TBK1) and IKKi (also called IKKvar epsilon), which catalyze IRF3 phosphorylation and stimulate its nuclear translocation and DNA binding.
p49
p49
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c137 : 1
stoichiometry:c142 : 1
stoichiometry:c138 : 1
m1599*m82*0.1
nodelay
--
0
PMID: 15950447, 12692549, 12702806 IRF3 activation occurs through the actions of the IKK-related kinases TRAF-family-member-associated NF-¦ÊB activator (TANK)-binding kinase 1 (TBK1) and IKKi (also called IKKvar epsilon), which catalyze IRF3 phosphorylation and stimulate its nuclear translocation and DNA binding.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c13 : 1
stoichiometry:c14 : 1
stoichiometry:c15 : 1
m16*m3962*0.1
nodelay
--
0
PMID: 15950447, 12524386 All TLRs possess amino-terminal leucine-rich repeats, which are responsible for the recognition of PAMPs, and also possess a carboxy-terminal Toll?interleukin-1 (IL-1) receptor (TIR) domain, which is required for initiating intracellular signaling.
p50
p50
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c139 : 1
stoichiometry:c144 : 1
stoichiometry:c140 : 1
m1599*m83*0.1
nodelay
--
0
PMID: 15950447, 12692549, 12702806 IRF3 activation occurs through the actions of the IKK-related kinases TRAF-family-member-associated NF-¦ÊB activator (TANK)-binding kinase 1 (TBK1) and IKKi (also called IKKvar epsilon), which catalyze IRF3 phosphorylation and stimulate its nuclear translocation and DNA binding.
p51
p51
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c145 : 1
stoichiometry:c147 : 1
stoichiometry:c148 : 1
stoichiometry:c146 : 1
m977*m85*m84*0.1
nodelay
--
0
PMID: 15950447, 12692549, 12702806 IRF3 activation occurs through the actions of the IKK-related kinases TRAF-family-member-associated NF-¦ÊB activator (TANK)-binding kinase 1 (TBK1) and IKKi (also called IKKvar epsilon), which catalyze IRF3 phosphorylation and stimulate its nuclear translocation and DNA binding.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c149 : 1
stoichiometry:c150 : 1
m19324*0.1
nodelay
--
0
PMID: 15950447, 12692549, 12702806 IRF3 activation occurs through the actions of the IKK-related kinases TRAF-family-member-associated NF-¦ÊB activator (TANK)-binding kinase 1 (TBK1) and IKKi (also called IKKvar epsilon), which catalyze IRF3 phosphorylation and stimulate its nuclear translocation and DNA binding.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c153 : 1
stoichiometry:c151 : 1
m86*0.1
nodelay
--
0
PMID: 15950447, 11698465, 12855817 Stimulation of macrophages and DCs with LPS and dsRNA results in the activation of the transcription factor IFN regulatory factor 3 (IRF3) and subsequent induction of IFN-beta and IFN-inducible genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c154 : 1
stoichiometry:c152 : 1
m86*0.1
nodelay
--
0
PMID: 15950447, 11698465, 12855817 Stimulation of macrophages and DCs with LPS and dsRNA results in the activation of the transcription factor IFN regulatory factor 3 (IRF3) and subsequent induction of IFN-beta and IFN-inducible genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c155 : 1
stoichiometry:c156 : 1
stoichiometry:c157 : 1
m183*m82*0.1
nodelay
--
0
PMID: 15950447, 14530355 TRAF6 is also reported to bind TRIF and cooperatively activate NF-kappaB.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c158 : 1
stoichiometry:c159 : 1
stoichiometry:c160 : 1
m88*m83*0.1
nodelay
--
0
PMID: 15950447, 14530355, 15064760 Furthermore, TRIF interacts with two different protein kinases, TBK1 and receptor-interacting protein-1 (RIP1).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c161 : 1
stoichiometry:c162 : 1
stoichiometry:c163 : 1
m183*m90*0.1
nodelay
--
0
PMID: 15950447, 14530355 TRAF6 is also reported to bind TRIF and cooperatively activate NF-kappaB.
p58
p58
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c164 : 1
stoichiometry:c169 : 1
stoichiometry:c165 : 1
m19*m89*0.1
nodelay
--
0
PMID: 15950447, 11698465 However, cells doubly deficient in TRAF6 and MyD88 still partially activated NF-kappaB in response to LPS, suggesting that TRIF activates NF-kappaB through both TRAF6-dependent and -independent pathways in TLR4 signaling.
p59
p59
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c166 : 1
stoichiometry:c168 : 1
stoichiometry:c167 : 1
m19*m91*0.1
nodelay
--
0
PMID: 15950447 Thus, TRIF is likely to use TBK1 and RIP1 for IRF3- and NF-kappaB activation, respectively, in TLR3 signaling. PMID: 15950447 In cells lacking RIP1, TLR3-mediated NF-kappaB activation and the subsequent induction of Icam-1 was severely impaired, whereas IFNbeta induction was intact.
p6
p6
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c16 : 1
stoichiometry:c17 : 1
stoichiometry:c18 : 1
m3966*m6485*0.1
nodelay
--
0
PMID: 15950447 TLR5 recognizes bacterial flagellin.
p60
p60
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c170 : 1
stoichiometry:c172 : 1
stoichiometry:c171 : 1
m19*m5*0.1
nodelay
--
0
PMID: 15950447, 11698465 However, cells doubly deficient in TRAF6 and MyD88 still partially activated NF-kappaB in response to LPS, suggesting that TRIF activates NF-kappaB through both TRAF6-dependent and -independent pathways in TLR4 signaling.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c173 : 1
stoichiometry:c174 : 1
m77*0.1
nodelay
--
0
PMID: 15950447 In cells lacking RIP1, TLR3-mediated NF-kappaB activation and the subsequent induction of Icam-1 was severely impaired, whereas IFNbeta induction was intact.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c176 : 1
stoichiometry:c179 : 1
stoichiometry:c180 : 1
m1572*m23*0.1
nodelay
--
0
PMID: 15950447, 12626561 It appears that IFN-alpha induction by TLR7 and TLR9 depends entirely on MyD88.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c175 : 1
stoichiometry:c177 : 1
stoichiometry:c178 : 1
m1572*m28*0.1
nodelay
--
0
PMID: 15950447, 12626561 It appears that IFN-alpha induction by TLR7 and TLR9 depends entirely on MyD88.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c182 : 1
stoichiometry:c183 : 1
stoichiometry:c184 : 1
m183*m94*0.1
nodelay
--
0
PMID: 15950447, 15361868, 15492225 IRF7 forms a signaling complex with MyD88 and TRAF6 in the cytoplasm.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c185 : 1
stoichiometry:c187 : 1
stoichiometry:c186 : 1
stoichiometry:c188 : 1
m93*m183*0.1
nodelay
--
0
PMID: 15950447, 15361868, 15492225 IRF7 forms a signaling complex with MyD88 and TRAF6 in the cytoplasm.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c181 : 1
stoichiometry:c192 : 1
m980*0.1
nodelay
--
0
PMID: 15950447, 15361868, 15492225 IRF7 forms a signaling complex with MyD88 and TRAF6 in the cytoplasm.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c189 : 1
stoichiometry:c190 : 1
stoichiometry:c191 : 1
m980*m96*0.1
nodelay
--
0
PMID: 15950447, 15361868, 15492225 IRF7 forms a signaling complex with MyD88 and TRAF6 in the cytoplasm.
p68
p68
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c194 : 1
stoichiometry:c195 : 1
stoichiometry:c198 : 1
m99*0.1
nodelay
--
0
PMID: 15950447 Similar to IRF3, phosphorylation is required for the activation of IRF7. PMID: 15950447, 15767370 In this regard, IRAK1 has been demonstrated to serve as an IRF7 kinase, and in IRAK1-deficient mice, TLR7- and TLR9-induced IFN-alpha production was completely abolished, although inflammatory cytokines were produced.
p69
p69
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c193 : 1
stoichiometry:c196 : 1
stoichiometry:c197 : 1
m98*0.1
nodelay
--
0
PMID: 15950447 Similar to IRF3, phosphorylation is required for the activation of IRF7. PMID: 15950447, 15767370 In this regard, IRAK1 has been demonstrated to serve as an IRF7 kinase, and in IRAK1-deficient mice, TLR7- and TLR9-induced IFN-alpha production was completely abolished, although inflammatory cytokines were produced.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c20 : 1
stoichiometry:c21 : 1
m19944*m21*0.1
nodelay
--
0
PMID: 15950447 TLR11 recognizes uropathigenic bacteria products.
p70
p70
cso30:i:ME_Translocation
cso30:i:CC_NuclearEnvelopeLumen
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c199 : 1
stoichiometry:c200 : 1
m19325*0.1
nodelay
--
0
PMID: 15950447, 15361868, 15492225 After stimulation, IRF7 translocates into the nucleus to induce IFN-alpha.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c202 : 1
stoichiometry:c201 : 1
m100*0.1
nodelay
--
0
PMID: 15950447, 15361868, 15492225 After stimulation, IRF7 translocates into the nucleus to induce IFN-alpha.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c204 : 1
stoichiometry:c203 : 1
m98717*0.1
nodelay
--
0
PMID: 15950447 Accordingly, pDCs respond to CpG DNA, by rapidly secreting large amounts of IFN-alpha. Synthesized ssRNA can also induce IFN-alpha via TLR7.
p73
p73
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c205 : 1
stoichiometry:c206 : 1
stoichiometry:c207 : 1
m101*m979*0.1
nodelay
--
0
PMID: 15950447, 15665823, 15695821 More recently, IRF5 has been shown to be involved in a MyD88?TRAF6 complex.
p74
p74
cso30:i:ME_UnknownActivation
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c208 : 1
stoichiometry:c209 : 1
stoichiometry:c210 : 1
m102*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c211 : 1
stoichiometry:c212 : 1
m103*0.1
nodelay
--
0
PMID: 15950447, 15665823 Upon TLR ligand stimulation, IRF5 was shown to translocate to the nucleus from the cytoplasm and bind the potential IFN-stimulated response element (ISRE) motifs present in the promoter region of proinflammatory cytokine genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c213 : 1
stoichiometry:c215 : 1
stoichiometry:c214 : 1
m106*m104*0.1
nodelay
--
0
PMID: 15950447, 15665823 Upon TLR ligand stimulation, IRF5 was shown to translocate to the nucleus from the cytoplasm and bind the potential IFN-stimulated response element (ISRE) motifs present in the promoter region of proinflammatory cytokine genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c217 : 1
stoichiometry:c216 : 1
m105*0.1
nodelay
--
0
PMID: 15950447 These observations indicate that IRF5 is a general signal transducer that mediates MyD88-dependent gene induction of proinflammatory cytokines, in contrast to IRF7, which requires MyD88-dependent IFN-alpha induction.
p78
p78
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c218 : 1
stoichiometry:c220 : 1
stoichiometry:c219 : 1
m769*m23*0.1
nodelay
--
0
PMID: 15950447, 15153500 In these cells, TLR9-stimulated NF-kappaB activation was unexpectedly impaired, suggesting that IRF8 mediates NF-kappaB activation in TLR9 signaling.
p79
p79
cso30:i:ME_UnknownActivation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c221 : 1
stoichiometry:c223 : 1
stoichiometry:c222 : 1
m19*m108*0.1
nodelay
--
0
PMID: 15950447, 15153500 In these cells, TLR9-stimulated NF-kappaB activation was unexpectedly impaired, suggesting that IRF8 mediates NF-kappaB activation in TLR9 signaling.
p8
p8
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c22 : 1
stoichiometry:c23 : 1
stoichiometry:c24 : 1
m22*m19828*0.1
nodelay
--
0
PMID: 15950447 TLR9 recognizes bacterial and viral CpG DNA motifs.
p80
p80
cso30:i:ME_GeneExpression
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c234 : 1
stoichiometry:c225 : 1
m16522*0.1
nodelay
--
0
PMID: 15950447, 14978071, 15067049 For example, various TLR2 ligands induce abundant IL-10 and favor Th2-biased immune responses both in human and mice, whereas ligands for TLR4, TLR5 and TLR9 induce Th1-associated cytokines, such as IL-12p70. PMID: 15950447 It was demonstrated that TLR2 ligands induce a higher phosphorylation of ERK and stabilization of the transcription factor c-Fos in DCs, which results in induction of IL-10 and suppression of IL-12p70.
p81
p81
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c226 : 1
stoichiometry:c237 : 1
stoichiometry:c229 : 1
m23*0.1
nodelay
--
0
PMID: 15950447, 14978071, 15067049 For example, various TLR2 ligands induce abundant IL-10 and favor Th2-biased immune responses both in human and mice, whereas ligands for TLR4, TLR5 and TLR9 induce Th1-associated cytokines, such as IL-12p70. PMID: 15950447 It was demonstrated that TLR2 ligands induce a higher phosphorylation of ERK and stabilization of the transcription factor c-Fos in DCs, which results in induction of IL-10 and suppression of IL-12p70.
p82
p82
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c228 : 1
stoichiometry:c236 : 1
stoichiometry:c230 : 1
m5*0.1
nodelay
--
0
PMID: 15950447, 14978071, 15067049 For example, various TLR2 ligands induce abundant IL-10 and favor Th2-biased immune responses both in human and mice, whereas ligands for TLR4, TLR5 and TLR9 induce Th1-associated cytokines, such as IL-12p70. PMID: 15950447 It was demonstrated that TLR2 ligands induce a higher phosphorylation of ERK and stabilization of the transcription factor c-Fos in DCs, which results in induction of IL-10 and suppression of IL-12p70.
p83
p83
cso30:i:ME_GeneExpression
cso30:i:CC_Nucleoplasm
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c227 : 1
stoichiometry:c235 : 1
stoichiometry:c231 : 1
m18*0.1
nodelay
--
0
PMID: 15950447, 14978071, 15067049 For example, various TLR2 ligands induce abundant IL-10 and favor Th2-biased immune responses both in human and mice, whereas ligands for TLR4, TLR5 and TLR9 induce Th1-associated cytokines, such as IL-12p70. PMID: 15950447 It was demonstrated that TLR2 ligands induce a higher phosphorylation of ERK and stabilization of the transcription factor c-Fos in DCs, which results in induction of IL-10 and suppression of IL-12p70.
p84
p84
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c232 : 1
stoichiometry:c224 : 1
stoichiometry:c233 : 1
m32*m110*0.1
nodelay
--
0
PMID: 15950447 It was demonstrated that TLR2 ligands induce a higher phosphorylation of ERK and stabilization of the transcription factor c-Fos in DCs, which results in induction of IL-10 and suppression of IL-12p70.
p85
p85
cso30:i:ME_Translation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c238 : 1
stoichiometry:c240 : 1
stoichiometry:c239 : 1
m19314*m111*0.1
nodelay
--
0
PMID: 15950447 For example, intracellular introduction of dsRNA stimulates DCs lacking TLR3 to secrete type I IFN.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c241 : 1
stoichiometry:c242 : 1
m86*0.1
nodelay
--
0
PMID: 15950447, 12855817, 15210742 TRIF but does require TBK1 and IRF3.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c243 : 1
stoichiometry:c244 : 1
stoichiometry:c245 : 1
m119368*m112*0.1
nodelay
--
0
PMID: 15950447, 15208624 Retinoic acid-inducible gene I has recently been identified as an intracellular sensor for dsRNA, and is composed of the RNA helicase domain, which binds dsRNA, and the caspase recruitment domain (CARD), which culminates in IRF3 activation.
p88
p88
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c246 : 1
stoichiometry:c248 : 1
stoichiometry:c249 : 1
stoichiometry:c250 : 1
stoichiometry:c247 : 1
m977*m113*m88*m1814*0.1
nodelay
--
0
PMID: 15950447, 15208624 Retinoic acid-inducible gene I has recently been identified as an intracellular sensor for dsRNA, and is composed of the RNA helicase domain, which binds dsRNA, and the caspase recruitment domain (CARD), which culminates in IRF3 activation. PMID: 15950447, 15549108 Fas-associated death domain (FADD) and RIP1 have been demonstrated to be involved in this pathway.
p89
p89
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c251 : 1
stoichiometry:c256 : 1
stoichiometry:c252 : 1
m4923*m155701*0.1
nodelay
--
0
PMID: 15950447, 15476921 NOD1 and NOD2 recognize naturally occurring degradation products and minimal motifs of bacterial peptidoglycan.
p9
p9
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c25 : 1
stoichiometry:c26 : 1
stoichiometry:c27 : 1
m25*m19828*0.1
nodelay
--
0
PMID: 15950447 TLR9 also recognizes non-nucleic acids, such as hemozoin.
p90
p90
cso30:i:ME_Binding
cso30:i:CC_Extracellular
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c253 : 1
stoichiometry:c255 : 1
stoichiometry:c254 : 1
m4947*m155701*0.1
nodelay
--
0
PMID: 15950447, 15476921 NOD1 and NOD2 recognize naturally occurring degradation products and minimal motifs of bacterial peptidoglycan.
p91
p91
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c257 : 1
stoichiometry:c259 : 1
stoichiometry:c261 : 1
m360980*m4923*0.1
nodelay
--
0
PMID: 15950447, 15476921 NOD1 and NOD2 recognize naturally occurring degradation products and minimal motifs of bacterial peptidoglycan.
p92
p92
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c258 : 1
stoichiometry:c260 : 1
stoichiometry:c262 : 1
m360980*m4947*0.1
nodelay
--
0
PMID: 15950447, 15476921 NOD1 and NOD2 recognize naturally occurring degradation products and minimal motifs of bacterial peptidoglycan.
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputInhibitor
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--